However, CM-272 reduced levels of the transcriptional repression mark H3K9me2 bound to the promoter regions of SCARA5 and AOX1, which suggests that, at least in NSCLC cancer cells, this may constitute a main mechanism of activity. The gene discussed is AOX1; the disease is cancer.